Subscribe To
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
BOSTON, MASSACHUSETTS, Dec. 14, 2022 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral causing diseases announced that it has established an Indian subsidiary (Pharmalectin India Private Limited). The purpose of the subsidiary is to launch commercial product sales […] The post Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization appeared first on F...
Read More
Posted: Dec 14 2022, 12:00
Author Name: forextv
Views: 102837